Health care stocks were steady pre-bell Wednesday as the Health Care Select Sector SPDR Fund (XLV) and the iShares Biotechnology ETF (IBB) were flat recently.
Cross Country Healthcare (CCRN) shares surged past 62% after the company and Aya Healthcare announced an agreement under which Aya will acquire Cross Country Healthcare for $18.61 per share in cash for roughly $615 million in transaction value.
Heron Therapeutics (HRTX) shares rose by over 72% after the company said it won a patent dispute over its Cinvanti injectable emulsion against Fresenius Kabi USA.
Novavax (NVAX) shares were up over 2% after the company said it has agreed to sell its manufacturing facility in Bohumil, Czech Republic, to Novo Nordisk (NVO) for $200 million.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。